283 related articles for article (PubMed ID: 8994122)
1. High resolution proton MR spectroscopy of cerebrospinal fluid in MS patients. Comparison with biochemical changes in demyelinating plaques.
Simone IL; Federico F; Trojano M; Tortorella C; Liguori M; Giannini P; Picciola E; Natile G; Livrea P
J Neurol Sci; 1996 Dec; 144(1-2):182-90. PubMed ID: 8994122
[TBL] [Abstract][Full Text] [Related]
2. Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study.
Simone IL; Tortorella C; Federico F; Liguori M; Lucivero V; Giannini P; Carrara D; Bellacosa A; Livrea P
J Neurol Sci; 2001 Jan; 182(2):143-50. PubMed ID: 11137520
[TBL] [Abstract][Full Text] [Related]
3. A multiparametric data analysis showing the potential of localized proton MR spectroscopy of the brain in the metabolic characterization of neurological diseases.
Confort-Gouny S; Vion-Dury J; Nicoli F; Dano P; Donnet A; Grazziani N; Gastaut JL; Grisoli F; Cozzone PJ
J Neurol Sci; 1993 Sep; 118(2):123-33. PubMed ID: 8229060
[TBL] [Abstract][Full Text] [Related]
4. Soluble intercellular adhesion molecule-1 in serum and cerebrospinal fluid of clinically active relapsing-remitting multiple sclerosis: correlation with Gd-DTPA magnetic resonance imaging-enhancement and cerebrospinal fluid findings.
Trojano M; Avolio C; Simone IL; Defazio G; Manzari C; De Robertis F; Calò A; Livrea P
Neurology; 1996 Dec; 47(6):1535-41. PubMed ID: 8960741
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal Fluid Dynamics in Patients with Multiple Sclerosis: The Role of Phase-Contrast MRI in the Differential Diagnosis of Active and Chronic Disease.
Öner S; Kahraman AS; Özcan C; Özdemir ZM; Ünlü S; Kamışlı Ö; Öner Z
Korean J Radiol; 2018; 19(1):72-78. PubMed ID: 29354002
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory multiple-sclerosis plaques generate characteristic metabolic profiles in cerebrospinal fluid.
Lutz NW; Viola A; Malikova I; Confort-Gouny S; Audoin B; Ranjeva JP; Pelletier J; Cozzone PJ
PLoS One; 2007 Jul; 2(7):e595. PubMed ID: 17611627
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid metabolic profiles in multiple sclerosis and degenerative dementias obtained by high resolution proton magnetic resonance spectroscopy.
Nicoli F; Vion-Dury J; Confort-Gouny S; Maillet S; Gastaut JL; Cozzone PJ
C R Acad Sci III; 1996 Jul; 319(7):623-31. PubMed ID: 9011324
[TBL] [Abstract][Full Text] [Related]
8. Nuclear magnetic resonance study of cerebrospinal fluid from patients with multiple sclerosis.
Lynch J; Peeling J; Auty A; Sutherland GR
Can J Neurol Sci; 1993 Aug; 20(3):194-8. PubMed ID: 8221382
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance spectroscopy of memory and frontal brain region in early multiple sclerosis.
Staffen W; Zauner H; Mair A; Kutzelnigg A; Kapeller P; Stangl H; Raffer E; Niederhofer H; Ladurner G
J Neuropsychiatry Clin Neurosci; 2005; 17(3):357-63. PubMed ID: 16179658
[TBL] [Abstract][Full Text] [Related]
10. Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis.
Matthews PM; Francis G; Antel J; Arnold DL
Neurology; 1991 Aug; 41(8):1251-6. PubMed ID: 1650931
[TBL] [Abstract][Full Text] [Related]
11. Metabolite abnormalities in progressive multifocal leukoencephalopathy by proton magnetic resonance spectroscopy.
Chang L; Ernst T; Tornatore C; Aronow H; Melchor R; Walot I; Singer E; Cornford M
Neurology; 1997 Apr; 48(4):836-45. PubMed ID: 9109865
[TBL] [Abstract][Full Text] [Related]
12. Metabolomic profiling of CSF in multiple sclerosis and neuromyelitis optica spectrum disorder by nuclear magnetic resonance.
Kim HH; Jeong IH; Hyun JS; Kong BS; Kim HJ; Park SJ
PLoS One; 2017; 12(7):e0181758. PubMed ID: 28746356
[TBL] [Abstract][Full Text] [Related]
13. The contribution of (1)H-magnetic resonance spectroscopy in defining the pathophysiology of multiple sclerosis.
Simone IL; Tortorella C; Federico F
Ital J Neurol Sci; 1999; 20(5 Suppl):S241-5. PubMed ID: 10662956
[TBL] [Abstract][Full Text] [Related]
14. Proton MR spectroscopy and MR imaging in acute and chronic multiple sclerosis--ringlike appearances in acute plaques.
Landtblom AM; Sjöqvist L; Söderfeldt B; Nyland H; Thuomas KA
Acta Radiol; 1996 May; 37(3 Pt 1):278-87. PubMed ID: 8845254
[TBL] [Abstract][Full Text] [Related]
15. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis.
Chowdhury SA; Lin J; Sadiq SA
Arch Neurol; 2008 Feb; 65(2):232-5. PubMed ID: 18268193
[TBL] [Abstract][Full Text] [Related]
16. Conventional and advanced magnetic resonance imaging in tumefactive demyelination.
Saini J; Chatterjee S; Thomas B; Kesavadas C
Acta Radiol; 2011 Dec; 52(10):1159-68. PubMed ID: 22025739
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid lactate and glutamine are reduced in multiple sclerosis.
Aasly J; Gårseth M; Sonnewald U; Zwart JA; White LR; Unsgård G
Acta Neurol Scand; 1997 Jan; 95(1):9-12. PubMed ID: 9048978
[TBL] [Abstract][Full Text] [Related]
18. Proton magnetic resonance spectroscopy of cerebrospinal fluid as an aid in neurological diagnosis.
Hiraoka A; Miura I; Hattori M; Tominaga I; Kushida K; Maeda M
Biol Pharm Bull; 1994 Jan; 17(1):1-4. PubMed ID: 8148794
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid molecular demonstration of Chlamydia pneumoniae DNA is associated to clinical and brain magnetic resonance imaging activity in a subset of patients with relapsing-remitting multiple sclerosis.
Contini C; Cultrera R; Seraceni S; Castellazzi M; Granieri E; Fainardi E
Mult Scler; 2004 Aug; 10(4):360-9. PubMed ID: 15327030
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis.
Fainardi E; Rizzo R; Melchiorri L; Castellazzi M; Paolino E; Tola MR; Granieri E; Baricordi OR
Mult Scler; 2006 Feb; 12(1):2-12. PubMed ID: 16459714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
